Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Breast Cancer Risk Assessment and Chemoprevention Use Among Veterans Affairs Primary Care Providers: A National Online Survey.
Journal: Military medicine
Published: January 10, 2019
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.
Journal: PloS one
Published: June 25, 2018
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 25, 2017
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
Journal: BMC urology
Published: October 14, 2016
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
Journal: Ecancermedicalscience
Published: July 15, 2016
Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 06, 2016
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
Journal: Cancer immunology, immunotherapy : CII
Published: November 03, 2015
Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue.
Journal: Clinical neurology and neurosurgery
Published: September 05, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026